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Introduction:  Renal primitive neuroectodermal tumor (PNET) is a rare and aggressive renal tumor with few
reported cases in the literature.
Observations:  We report a case of a 23-year-old male patient who initially presented with features of an
inflammatory renal space occupying lesion (SOL) on clinical evaluation and imaging. Guided fine-needle
aspiration cytology from renal mass revealed poorly differentiated neoplasm. Left open radical nephrectomy
was performed. Final histopathology examination, despite the absence of clinical, radiological and gross
features was consistent with a diagnosis of renal PNET. Such uncommon presentation of renal PNET
has been rarely reported in the literature. Our patient then received six cycles of adjuvant chemotherapy
(vincristine 1.5 mg/m2 on day 1, doxorubicin 20 mg/m2 on days 1–3, etoposide 150 mg/m2 on days 1–3,
and ifosfamide 3 g/m2 on days 1–3 with mesna every 21 days). The patient developed multiorgan metastasis
and progressive disease after remaining disease-free for 14 months.
Conclusion:  Renal PNET should be kept in the differentials of a renal SOL presenting in adolescents and
young adults. All diagnostic modalities concerning SOL of the kidney must be interpreted with caution in
order for the appropriate management. Punctures for cytology can be indicated in select cases. Histopathol-
ogy, immuno histochemistry supported by cytogenetic studies are required for the exact diagnosis of renal
PNET. Multidisciplinary approach consisting of surgery, chemotherapy, and radiotherapy is recommended
to manage this condition in view of its aggressive nature and poor prognosis.
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Figure  2  Image showing surgically excised left kidney depicting
large encapsulated lesion with solid cystic areas.36 
ntroduction
enal primitive neuroectodermal tumor (PNET) is a rare renal tumor
ith few reported cases in the literature [1–3]. Since this entity has
o characteristic features on clinical examination and imaging it
ay present with confusing features. A 23-year-old man presented
ith left flank pain and fever for one month. Imaging revealed a large
ildly enhancing mixed density space occupying lesion (SOL) in
eft kidney with adjacent fat stranding suggesting an inflammatory
ass. Guided fine-needle aspiration cytology from renal mass was
one and revealed poorly differentiated neoplasm. Left open radical
ephrectomy was performed and the final histopathology examina-
ion, despite the absence of clinical, radiological and gross features
ere consistent with a diagnosis of renal PNET.
ase  presentation
 23-year-old male patient presented with discomfort in the left
oin with a history of fever for last one month. On examination, he
ooked pale. A lump was palpable in the left upper quadrant and
umbar region measuring around 10 cm ×  8 cm ×  6 cm. His pulse
ate was 125/min, BP 120/85 mmHg and temp 39.2 ◦C. Except
or mild anemia and leucocytosis, his routine blood tests were
ormal (Hb 9.2 g/dL, TLC 13.6 ×  109/l and Platelets 156 ×  109/l;
lood urea 4.9 mmol/l and creatinine 70 m/l). Chest X-ray did
ot reveal any abnormality. An ultrasound (US) examination of the
bdomen showed a voluminous cystic SOL in the mid pole of the
eft kidney. To better evaluate the US findings, a contrast-enhanced
omputed tomography (CECT) scan of the abdomen was performed
hat revealed a large (14 cm ×  12 cm ×  8 cm) roundish mixed den-
ity solid cystic lesion with interrupted peripheral rim calcifications
redominantly involving upper and mid-pole of the left kidney with
inimal enhancement and adjacent perinephric fat plain stranding
Fig. 1). In view of atypical presentation and radiologic features
mage-guided FNAB was performed which revealed poorly dif-
erentiated neoplasm. The patient was planned for surgery and he
nderwent left radical nephrectomy with open access that showed
 friable yellow lesion, partially cystic (Fig. 2); it was difficult to
igure  1  Computerized tomography scan image of abdomen depict-
ng mildly enhancing large roundish mixed density solid cystic lesion in
eft kidney with interrupted peripheral rim calcifications. The lesion also
hows internal non-enhancing necrotic areas and adjacent perinephric
at stranding.
Figure  3  Scanner view showing an encapsulated tumor tissue show-















issociate the SOL from adjacent organs because of many adhe-
ions. However, the final histological report came as a surprise to us
nd revealed PNET limited to the left kidney. Microscopy revealed
he presence of small round cells (Fig. 3). Immuno-histochemistry
evealed strong immunostaining for CD99 (Fig. 4), S100, and
euron-specific enolase. Vimentin staining was focally positive and
K20 and WT-1 were negative. Our patient then received six cycles
f adjuvant chemotherapy (VIDE; vincristine, ifosfamide, doxoru-
icin, and etoposide) consisting of vincristine 1.5 mg/m2 on day 1,
oxorubicin 20 mg/m2 on days 1–3, etoposide 150 mg/m2 on days
–3, and ifosfamide 3 g/m2 on days 1–3 with mesna every 21 days,
ll intravenously (I.V.) with granulocyte-colony stimulating fac-
or. The patient developed multiorgan metastasis and progressive
isease after remaining disease-free for 14 months.
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Discussion
Renal PNET is a rare renal tumor first described by Seemayer et al.
in 1975 [1]. Around 100 case reports have been so far published
with few cases reported from India [2,3]. The largest case series
of 34 cases were described by Karpate et al. in 2012 [3]. It mainly
occurs in adolescents and young adults, with an average presen-
tation age of 27 years and has a slight male predominance [4,5].
Renal PNET usually presents with nonspecific symptoms, includ-
ing flank pain, hematuria and symptoms related to genitourinary
infections [2–5]. CT scan images have no characteristic features to
differentiate it from other tumors, most commonly there are large,
heterogenous masses with variable areas of hemorrhage or necro-
sis manifesting as areas of enhancement with diffuse calcifications
[6]. Atypical solid kidney masses such as in present case present a
challenge for definitive radiologic characterization. In the evalua-
tion of renal masses, renal fine needle aspiration biopsy (FNAB) has
become an exceptional procedure in this era of renal helical com-
puted tomography (CT), which has a high diagnostic accuracy in the
characterization of renal cortical lesions. There are mainly four dis-
tinct indications for renal FNAB: (a) solid renal masses with atypical
radiological features or poorly characterized on imaging studies, (b)
confirmation of radiological suspected renal malignancy in inoper-
able patients (advanced stage disease or poor surgical candidate
status), (c) kidney mass in a patient with a prior history of other
malignancy, and (d) miscellaneous (drainage of abscess, indetermi-
nate cystic lesion, urothelial carcinoma [7]. An image-guided renal
mass biopsy is safe, reliable and accurate, and it changes clinical
management in many cases by avoiding nephrectomy or other sur-
gical options [8]. Microscopically renal PNET is characterized by
primitive appearing round cells with the high nucleo-cytoplasmic
ratio, perivascular pseudo-rossetes, typical Homer-Wright rossetes
[4]. Immunohistochemically, renal PNET shows positivity for CD
99 and FLI-1 with variable positivity for neuroendocrine markers
like NSE, vimentin and S 100 with no expression of WT-1 [9].
A combination of markers is generally helpful in arriving the correct
diagnosis. Cytogenetic study of renal PNET is a supportive method
to make the final diagnosis. Most of the tumors show chromoso-
mal translocation t(11;22)(q24;q12) [10]. Hence the diagnosis of
renal PNET is confirmed by histopathology and immunohistochem-
istry in nephrectomy specimens and is supported by the cytogenetic
study (not done in our case). Multi-modal treatment approach
including surgery (radical nephrectomy), adjuvant chemotherapy137
vincristine, adriamycin, cyclophosphamide with alternating ifos-
amide and etoposide every 21 days – VAC/IE) and radiotherapy is
he cornerstone for the management of this aggressive renal malig-
ancy. Adjuvant radiation therapy is recommended for patients with
ncomplete resection, positive resection margins, or recurrence [9].
he overall prognosis of this condition is poor due to lack of discrete
linical and radiological findings which make preoperative diagno-
is difficult, the strong tendency of local recurrence and remote
etastases to organs such as lungs, liver, and bone.
onclusions
enal PNET is a rare renal malignancy that should be kept in
he differentials of a renal SOL presenting in adolescents and
oung adults. Histopathology, immuno histochemistry supported
y cytogenetic studies are required for the exact diagnosis. Mul-
idisciplinary approach consisting of surgery, chemotherapy, and
adiotherapy is recommended to manage this condition in view of
ts aggressive nature and poor prognosis. All diagnostic modalities
oncerning space-occupying lesions (SOL) of the kidney must be
nterpreted with caution in order for the appropriate management.
unctures for cytology can be indicated in select cases.
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